Save your place

Sign in to WhoBought

Please try again later.

Perspective Therapeutics, Inc. (CATX) institutional ownership

Latest close $2.87 Jul 28, 2026
Market cap$273M 52-week range SectorHealthcare
Funds holding · Q1 2026
134
reported CATX position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Activity unavailable N/A
84 buyers · 50 sellers

Perspective Therapeutics, Inc. (CATX) price and institutional activity

Dates

Q1 2026

$0 bought by 84 investors
Tcg Crossover Management, LLCCommodore Capital LP +82 more
$0 sold by 50 investors
Morgan StanleyTwo Sigma Advisers, LP +48 more
Bought Sold Totals per quarter; hover a bar for the names.

Perspective Therapeutics, Inc. (CATX) institutional activity · 134

Investor Type Est. change Change Δ Own Date
Tcg Crossover Management, LLC · New
Change +7.9M Date Q1 2026
Tcg Crossover Management, LLC New· Q1 2026 +7.9M Q1 2026
Commodore Capital LP · New
Change +6.3M Date Q1 2026
Commodore Capital LP New· Q1 2026 +6.3M Q1 2026
Opaleye Management Inc. · Added
Change +3.5M Date Q1 2026
Opaleye Management Inc. Added· Q1 2026 +3.5M Q1 2026
Citadel Advisors LLC Added· Q1 2026 +3.3M +1218.5% Q1 2026
Balyasny Asset Management L.P. · New
Change +3.0M Date Q1 2026
Balyasny Asset Management L.P. New· Q1 2026 +3.0M Q1 2026
Affinity Asset Advisors, LLC · Added
Change +2.9M Date Q1 2026
Affinity Asset Advisors, LLC Added· Q1 2026 +2.9M Q1 2026
Avidity Partners Management LP · Added
Change +2.8M Date Q1 2026
Avidity Partners Management LP Added· Q1 2026 +2.8M Q1 2026
Millennium Management LLC · Added
Change +2.6M Date Q1 2026
Millennium Management LLC Added· Q1 2026 +2.6M Q1 2026
Spruce Street Capital LP · New
Change +2.6M Date Q1 2026
Spruce Street Capital LP New· Q1 2026 +2.6M Q1 2026
Vanguard · Added
Change +2.3M Date Q1 2026
Vanguard Added· Q1 2026 +2.3M Q1 2026
State Street · Added
Change +2.0M Date Q1 2026
State Street Added· Q1 2026 +2.0M Q1 2026
Morgan Stanley · Reduced
Change −1.5M Date Q1 2026
Morgan Stanley Reduced· Q1 2026 −1.5M Q1 2026
Goldman Sachs Group Inc · Added
Change +1.1M Date Q1 2026
Goldman Sachs Group Inc Added· Q1 2026 +1.1M Q1 2026
Yu Fan · New
Change +1.1M Date Q1 2026
Yu Fan New· Q1 2026 +1.1M Q1 2026
Ally Bridge Group (ny) LLC · New
Change +927K Date Q1 2026
Ally Bridge Group (ny) LLC New· Q1 2026 +927K Q1 2026
Data through Q1 2026 · filed Jun 4, 2026
15 of 134

Famous investor activity in Perspective Therapeutics, Inc. (CATX)

Perspective Therapeutics, Inc. (CATX) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Martinez Maria E. · Director Grant (A) 50K
Owned 50K Trade date Mar 2, 2026 Filed date Mar 4, 2026
Martinez Maria E. Director Grant (A) 50K 50K Mar 2, 2026 Mar 4, 2026
Morich Frank · Director Grant (A) 50K
Owned 50K Trade date Mar 2, 2026 Filed date Mar 4, 2026
Morich Frank Director Grant (A) 50K 50K Mar 2, 2026 Mar 4, 2026
Williamson Robert F. III · Director Grant (A) 50K
Owned 50K Trade date Mar 2, 2026 Filed date Mar 4, 2026
Williamson Robert F. III Director Grant (A) 50K 50K Mar 2, 2026 Mar 4, 2026
Henson Heidi · Director Grant (A) 50K
Owned 50K Trade date Mar 2, 2026 Filed date Mar 4, 2026
Henson Heidi Director Grant (A) 50K 50K Mar 2, 2026 Mar 4, 2026
Woods Lori A. · Director Grant (A) 50K
Owned 50K Trade date Mar 2, 2026 Filed date Mar 4, 2026
Woods Lori A. Director Grant (A) 50K 50K Mar 2, 2026 Mar 4, 2026
Spoor Johan M. · Director, Officer Grant (A) 735K
Owned 735K Trade date Mar 2, 2026 Filed date Mar 4, 2026
Spoor Johan M. Director, Officer Grant (A) 735K 735K Mar 2, 2026 Mar 4, 2026
Hunt Jonathan Robert · Officer Grant (A) 90K
Owned 90K Trade date Mar 2, 2026 Filed date Mar 4, 2026
Hunt Jonathan Robert Officer Grant (A) 90K 90K Mar 2, 2026 Mar 4, 2026
Puhlmann Markus · Officer Grant (A) 150K
Owned 150K Trade date Mar 2, 2026 Filed date Mar 4, 2026
Puhlmann Markus Officer Grant (A) 150K 150K Mar 2, 2026 Mar 4, 2026
Hunt Jonathan Robert · Officer Buy +$22K
Price $2.03 Qty +11K Owned 60K Trade date Nov 13, 2025 Filed date Nov 17, 2025
Hunt Jonathan Robert Officer Buy $2.03 +11K +$22K 60K Nov 13, 2025 Nov 17, 2025
Williamson Robert F. III · Director Buy +$20K
Price $2.10 Qty +9K Owned 10K Trade date Nov 12, 2025 Filed date Nov 14, 2025
Williamson Robert F. III Director Buy $2.10 +9K +$20K 10K Nov 12, 2025 Nov 14, 2025
Sendek Joel · Officer Grant (A) 600K
Owned 600K Trade date Sep 4, 2025 Filed date Sep 5, 2025
Sendek Joel Officer Grant (A) 600K 600K Sep 4, 2025 Sep 5, 2025
Martinez Maria E. · Director Grant (A) 75K
Owned 75K Trade date Sep 3, 2025 Filed date Sep 5, 2025
Martinez Maria E. Director Grant (A) 75K 75K Sep 3, 2025 Sep 5, 2025
12 of 12

Perspective Therapeutics, Inc. (CATX) activist and large shareholders

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
Lantheus Holdings, Inc. 116.8M
% of shares outstanding 19.9% Filing date Mar 8, 2024
Lantheus Holdings, Inc. 116.8M 19.9% Mar 8, 2024
FMR LLC 9.5M
% of shares outstanding 14.1% Filing date Nov 7, 2024
FMR LLC 9.5M 14.1% Nov 7, 2024
Janus Henderson Group PLC 4.8M
% of shares outstanding 7.1% Filing date Nov 14, 2024
Janus Henderson Group PLC 4.8M 7.1% Nov 14, 2024
Schultz Michael K 17.7M
% of shares outstanding 6.3% Filing date Sep 19, 2023
Schultz Michael K 17.7M 6.3% Sep 19, 2023
Johnson Frances 17.7M
% of shares outstanding 6.3% Filing date Sep 19, 2023
Johnson Frances 17.7M 6.3% Sep 19, 2023
Blackrock, Inc. 4.0M
% of shares outstanding 6.0% Filing date Nov 8, 2024
Blackrock, Inc. 4.0M 6.0% Nov 8, 2024
Millennium Management LLC 6.0M
% of shares outstanding 5.3% Filing date Jul 20, 2026
Millennium Management LLC 6.0M 5.3% Jul 20, 2026
Avidity Partners Management LP 3.6M
% of shares outstanding 5.3% Filing date Nov 14, 2024
Avidity Partners Management LP 3.6M 5.3% Nov 14, 2024
8 of 12

Perspective Therapeutics, Inc. (CATX) ownership FAQ

Who owns CATX?

134 reporting institutions disclosed CATX position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.